Cargando…
Postthrombolytic Antiplatelet Use for Patients with Intercerebral Hemorrhage without Extensive Parenchymal Involvement Does Not Worsen Outcome
BACKGROUND AND PURPOSE: It is unclear whether postthrombolytic antiplatelet (AP) therapy after thrombolytic-related hemorrhage without extensive parenchymal involvement (THEPI) affects the clinical outcome. This study explored whether AP administration in patients with THEPI affects short- and long-...
Autores principales: | Jia, Weihua, Zhou, Lichun, Liao, Xiaoling, Pan, Yuesong, Wang, Yongjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neurological Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596115/ https://www.ncbi.nlm.nih.gov/pubmed/26424236 http://dx.doi.org/10.3988/jcn.2015.11.4.305 |
Ejemplares similares
-
Thrombolytic-Related Asymptomatic Hemorrhagic Transformation Does Not Deteriorate Clinical Outcome: Data from TIMS in China
por: Jia, Weihua, et al.
Publicado: (2015) -
Hemorrhagic Transformation (HT) and Symptomatic Intracerebral Hemorrhage (sICH) Risk Prediction Models for Postthrombolytic Hemorrhage in the Stroke Belt
por: Siegler, James E., et al.
Publicado: (2013) -
Predictors of post-thrombolysis symptomatic intracranial hemorrhage in Chinese patients with acute ischemic stroke
por: Liu, Mingyong, et al.
Publicado: (2017) -
Differentiating between Hemorrhagic Infarct and Parenchymal Intracerebral Hemorrhage
por: Choi, P. M. C., et al.
Publicado: (2012) -
Intravenous tPA Therapy Does Not Worsen Acute Intracerebral Hemorrhage in Mice
por: Foerch, Christian, et al.
Publicado: (2013)